Elixxer Received a Binding Offer to Sell Viridi Stake for $1 Million
Elixxer Received a Binding Offer to Sell Viridi Stake for $1 Million
Montreal, Quebec--(Newsfile Corp. - March 29, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has received a binding offer for the sale of its 18.4% shareholdings in Viridi Unit SA to Global A Brands.
魁北克蒙特利爾-(Newsfile Corp.-2022年3月29日)-Elixer Ltd.(多倫多證券交易所股票代碼:ELXR)(場外交易代碼:ELIXF)(“艾力克索“或”公司)很高興地宣佈,它已收到一份具有約束力的要約,要求將其在Viridi單位SA的18.4%股份出售給Global A Brands。
The Global A Brands already owns the remaining 81.6% of Viridi. The binding offer values Elixxer's shares in Viridi at about CAN $1,000,000.
全球A品牌已經擁有Viridi剩餘的81.6%的股份。這份具有約束力的要約對Elixxer在Viridi的股票估值約為100萬加元。
The Company, under the previous management team, purchased the Viridi stocks on December 12, 2018. Elixxer's current carrying value of the Viridi shares is nil value on the balance sheet. This deal will strengthen the Company's balance sheet and increase EBITDA by about $1 million or $0.09 per share.
本公司在前管理團隊的領導下,於2018年12月12日購買了Viridi的股票。在資產負債表上,Elixxer目前持有的Viridi股票的賬面價值為零。這筆交易將加強公司的資產負債表,使EBITDA增加約100萬美元,即每股0.09美元。
The Company's management team have been actively looking for buyers to sell some or all of these minority holdings to strengthen its balance sheet, improve earnings and crystallise value for our shareholders.
該公司的管理團隊一直在積極尋找買家出售部分或全部這些少數股權,以加強其資產負債表,改善收益,併為我們的股東實現價值。
The management of Elixxer expect to complete the deal on or before April 15, 2022.
Elixer的管理層預計將在2022年4月15日或之前完成交易。
About Elixxer Ltd. ()
關於Elixxer Ltd.()
Elixxer is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).
Elixer是一家加拿大上市公司,在多倫多證券交易所創業板(TSXV:ELXR)和美國場外-QB交易所(OTCQB:ELIXF)上市。
Through its partners, Elixxer presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.
通過其合作伙伴,Elixer目前在澳大利亞、牙買加、瑞士、意大利和加拿大擁有重大利益。
About Global A Brands
關於全球A品牌
Global A Brands, Inc. (GAB), is a multinational company that acquires and develops early-stage businesses within the Luxury Goods and Lifestyle market segments. GAB controls ten subsidiaries that are each managed independently under the Company's four divisions Liquor, Cosmetics, Distribution and Gaming.
Global A Brands,Inc.(GAB)是一家跨國公司,在奢侈品和生活方式市場領域收購和發展早期業務。GAB控制着10家子公司,每一家子公司都在該公司的四個部門白酒、化粧品、分銷和遊戲下獨立管理。
For more information on Virisens, visit:
有關Virisens的更多信息,請訪問:
For more information on Global A Brands, visit:
有關全球A品牌的更多信息,請訪問:
For further information please contact:
欲瞭解更多信息,請聯繫:
Ferras Zalt, Chairman and Interim CEO: +44 20 7409 6680; ferras@elixxer.com
董事長兼臨時首席執行官費拉斯·扎爾特:+44 20 7409 6680電子郵件:ferras@elixxer.com
Caution Regarding Press Releases
有關新聞稿的注意事項
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
多倫多證券交易所創業板交易所及其監管服務提供商(該術語在多倫多證券交易所創業板政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Notice Regarding Forward-Looking Statements
關於前瞻性陳述的通知
This press release may contain forward-looking statements with respect to Elixxer and its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. The actual results and performance of Elixxer could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under "Risk Factors and Risk Management" in Elixxer's most recent Management's Discussion and Analysis filed on SEDAR (). The cautionary statements qualify all forward-looking statements attributable to Elixxer and persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, and Elixxer has no obligation to update such statements, except to the extent required by applicable securities laws.
本新聞稿可能包含有關Elixxer及其運營、戰略、投資、財務業績和狀況的前瞻性陳述。這些陳述通常可以通過使用“可能”、“將”、“預期”、“估計”、“預期”、“打算”、“相信”或“繼續”或其否定或類似變體等前瞻性詞語來識別。Elixer的實際結果和表現可能與此類陳述中表達或暗示的內容大不相同。這些陳述整體上受到圍繞未來預期的固有風險和不確定因素的限制。可能導致實際結果與預期大相徑庭的一些重要因素包括但不限於一般經濟和市場因素、競爭、政府監管以及Elixer在SEDAR()上的最新管理層討論和分析中“風險因素和風險管理”一節中描述的因素。警告性聲明限定了Elixxer和代表其行事的人的所有前瞻性聲明。除非另有説明,否則所有前瞻性陳述僅在本新聞稿發佈之日發表,除適用的證券法要求的範圍外,Elixxer沒有義務更新此類陳述。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問